Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference44 articles.
1. The role of CDK4/6 inhibition in breast cancer;Murphy;Oncologist,2015
2. Cyclin D1 in breast cancer pathogenesis;Arnold;J Clin Oncol,2005
3. ERalpha-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer;Miller;Cancer Discov,2011
4. Mechanisms of endocrine resistance in breast cancer;Osborne;Annu Rev Med,2011
5. The history and future of targeting cyclin-dependent kinases in cancer therapy;Asghar;Nat Rev Drug Discov,2015
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cyclin-dependent kinase 4 and 6 inhibitors in combination with neoadjuvant endocrine therapy in estrogen receptor-positive early breast cancer: a systematic review and meta-analysis;Clinical and Experimental Medicine;2022-03-19
2. Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer;Cancers;2021-12-16
3. Pathology of Neoadjuvant Systemic Therapy Response;Management of the Breast and Axilla in the Neoadjuvant Setting;2021-12-15
4. HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer;Breast Cancer Research and Treatment;2021-08-18
5. Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer;Pathology and Oncology Research;2021-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3